Overview

A Trial of Rivaroxaban Versus Warfarin in Dissolving Left Atrial Appendage Thrombus in Patients With Atrial Fibrillation

Status:
Not yet recruiting

Trial end date:
2022-12-30

Target enrollment:

Participant gender:

Summary

The purpose of this clinical randomized trial is to evaluate the efficacy and safety of rivaroxaban compared with warfarin in dissolving the LAA thrombus in patients with atrial fibrillation.

Phase:

N/A

Details

Lead Sponsor:

The Second Affiliated Hospital of Chongqing Medical University

Treatments:

Dalteparin
Heparin, Low-Molecular-Weight
Rivaroxaban
Warfarin